Born at SISSA in Trieste, Aindo is an Italian company that develops AI to generate realistic, secure, and compliant synthetic data. It enables healthcare companies and institutions to work with sensitive data without exposing it, making research, development, and clinical trials faster.
The 2023 rebrand with Moze opened an important new chapter for Aindo, currently focused on the healthcare sector.
In 2026, Aindo came back to Moze to evolve its identity and website in line with this new dimension. The goal was to communicate a more mature and authoritative positioning, capable of strengthening market trust and supporting the company's next stages of growth.
- Branding
- UX & UI Design
- Web Dev
An identity closer to the healthcare market
The work started with the brand. There was no need to start from scratch, but to bring out more clearly the role Aindo had taken on: an AI technology for clinical, regulated, and data-intensive contexts.
We updated the visual system to make it more essential, recognizable, and credible for the sector. Fewer generic AI codes, less predictable medical imagery, and more attention to message clarity.
A website to explain value and context
The work continued with the UX/UI design of the new website.
We redesigned the architecture, content, and interface to make the value of synthetic data easier to understand: protecting sensitive information, complying with regulatory constraints, and accelerating clinical research processes.
The result is a more direct website, designed to speak to technical, clinical, and business stakeholders without losing precision.
A modern, fast, and secure stack
We developed the website on a stack based on Astro JS, chosen for performance, security, and stability. A lightweight, fast technical foundation, ready to evolve together with the brand.
Daniele Panfilo CEO & Co-founder, Aindo
